Sytheon obtains a new US patent for treating dermatological diseases

Published: 21-Jul-2020 Featured companies: Sytheon
Ingredients Research & Development

US Patent: 10,597,402
Assignee: Sytheon
Title: Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases
Planned Commercial Product: Atopic Dermatitis

According to the present teaching there are provided novel esters of isosorbide that are found to improve and/or address defects or imbalances in keratinocyte differentiation, improve and/or repair skin barrier building and defense of its function and integrity as well as improve overall stratum corneum development, structure and architecture.

Specifically, it has now been found that certain esters of isosorbide are capable of modifying, recalibrating and/or regulating the expression of genes, genetic networks, and cellular pathways in mammalian skin for improving and/or repairing the epidermis and its function as well as in addressing, combating, mitigating and/or preventing the manifestation of disease conditions associated with certain diseases and defects or imbalances in the skin.

Securing this patent, Sytheon is now committed to enter, through its sister company Symbionyx Phamaceuticals Inc., to the dermatological market for treating diseases caused by autoimmune imbalances.

Featured companies

Sytheon is an innovative research-based company committed to developing high-performance active ingredients since 2006. Sytheon’s global headquarters is in the US with...
See more

You may also like

Ingredients

New application: Synastol TC (Terminalia Chebula Fruit Extract) now available as a nutritional supplement

Read more
Get your gut in the game of skin beauty – the science behind standardised Terminalia Chebula fruit extract for delivering beauty from the inside-out

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Future beauty forecasting from in-cosmetics Global 2024 Longevity, pre-ageing and AI-empowered ingredients were some standout themes from the Paris ingredients trade show last week
  2. Givaudan Active Beauty unveils Neuroglow, the active that captures the molecular power of the sun The new ingredient for glow and good mood
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    YSL Beauty accelerates global sustainability initiative with new rewilding projects The luxury beauty brand’s Rewild Our Earth programme, which aims to protect biodiversity, will fund new projects in Colombia and the Bahamas this year
  4. Lawsuits mount against Givaudan, Firmenich, IFF and Symrise amid fragrance antitrust investigation Texan business Crimson Candle Supplies leads US-based scented products companies in the latest class action filed against the fragrance giants
  5. Cosmetics Business reveals the top 5 skin care trends of 2024 in new report From the great peptide revival to Gen Alpha's hyper-engagement, this report opens the lid on latest trends to sizzle in skin care

Relevant companies

See more

Upcoming event

China Beauty Expo

22-24 May | Shanghai, China See all

You may also like

Ingredients

New application: Synastol TC (Terminalia Chebula Fruit Extract) now available as a nutritional supplement

Get your gut in the game of skin beauty – the science behind standardised Terminalia Chebula fruit extract for delivering beauty from the inside-out
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Ingredients innovation: Cosmetics Business rounds-up new beauty ingredient launches from August

This month’s selection of new cosmetic materials includes a more cost-effective HA and a ‘clean’ retinol product
Ingredients

Antioxidants Journal features review on Synoxyl AZ (Acetyl Zingerone)

The versatility of Synoxyl® AZ embodies the definition of a “next generation” skincare ingredient to maintain and augment skin’s beauty and health throughout life
Ingredients

Synoxyl AZ (Acetyl Zingerone) mitigate the dark side of melanin that may lead to melanoma

Sytheon in collaboration with Moffitt Cancer Center has published a study in the Antioxidants J (2023, 12(2), 278 doi.org/10.3390/antiox12020278), entitled “The Role of Acetyl Zingerone and Its Derivatives in Inhibiting UV-Induced, Incident, and Delayed Cyclobutane Pyrimidine Dimers”
Ingredients

Sytheon announces a new publication on Atopic Dermatitis

Sytheon is excited to announce a publication on synergistic anti-inflammatory effects of isosorbide fatty acid diesters in Cytokine-induced tissue culture models of Atopic Dermatitis
Ingredients

Sytenol A, the true Bakuchiol is now approved for use in China

Sytenol<sup>®</sup> A is a natural, vegan-friendly, retinol alternative that has the same benefits as retinol without the drawbacks
Ingredients

Sytheon announces relocation and expansion of new corporate headquarters

Sytheon relocates its headquarters to 10 Waterview Blvd, Parsippany, New Jersey
Subscribe now